InvestorsHub Logo

Easyman51

10/03/04 8:14 AM

#17716 RE: mingwan0 #17712

Now, perhaps people can appreciate Dr. Frudakis acquiring the high through-put equiptment from Orchid BioScience at the beginning.

As I see it, DnaPrint has roughly $18mil, before expenses & revenue over the next 20+ months. There is a cost to be born in doing business, so I am concervatively figuring 10% for the 51+%=$2.5mil, eh? La Jolla Grp. is already in for 22mil shares. Now aren't we happy there is 1.5bil shares available?

I see the business accumen being applied in this acquisition.
What a fortuetous opportunity presented to participate in a global effort to improve mankinds conditon. I feel honored.

Peace/Boat Drinks